Fate Therapeutics, Inc. (FATE) Earnings
NASDAQ·Healthcare·Biotechnology
$2.00
+5.26%
Mkt Cap $234.28M
EPS — Estimate vs Actual
Mkt Cap
$234.28M
P/E
—
Fwd P/E
—
P/S
37.09
Rev TTM
—
EPS TTM
-$1.09
NASDAQ·Healthcare·Biotechnology
$2.00
+5.26%
Mkt Cap $234.28M
Mkt Cap
$234.28M
P/E
—
Fwd P/E
—
P/S
37.09
Rev TTM
—
EPS TTM
-$1.09